Audentes Therapeutics is a leading AAV-based genetic medicines company focused on developing and commercializing innovative products for serious rare neuromuscular diseases. We are leveraging our AAV gene therapy technology platform and proprietary manufacturing expertise to develop programs across three modalities: gene replacement, vectorized exon skipping, and vectorized RNA knockdown. Our product candidates are showing promising therapeutic profiles in clinical and preclinical studies across a range of neuromuscular diseases. Audentes is a focused, experienced and passionate team driven by the goal of improving the lives of patients. If you are interested in learning more about our company, please do not hesitate to contact us.
View Top Employees from Audentes Therapeutics| Website | http://www.audentestx.com |
| Ticker | BOLD |
| Revenue | $6 million |
| Funding | $212.5 million |
| Employees | 406 (406 on RocketReach) |
| Founded | 2013 |
| Address | 600 California St, Fl 17, San Francisco, California 94108, US |
| Phone | (415) 818-1005 |
| Technologies |
JavaScript,
HTML,
PHP
+53 more
(view full list)
|
| Industry | Biotechnology, Education, Pharmaceuticals, Science and Engineering, Healthcare, Organizations, Genetics, Power Conversion & Protection Equipment, Health Care, Electronics, Health Diagnostics, Manufacturing, Aerospace & Defense, Business Services |
| Web Rank | 2 Million |
| Keywords | Genetic Testing |
| Competitors | AGTC, Abeona Therapeutics, Homology Medicines, Inc., REGENXBIO Inc., Voyager Therapeutics, Inc. |
| SIC | SIC Code 37 Companies, SIC Code 372 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies |
Looking for a particular Audentes Therapeutics employee's phone or email?
Audentes Therapeutics Questions
The Audentes Therapeutics annual revenue was $6 million in 2024.
Helga Stockton is the Vice President, Quality of Audentes Therapeutics.
406 people are employed at Audentes Therapeutics.
Audentes Therapeutics is based in San Francisco, California.
The NAICS codes for Audentes Therapeutics are [325, 5417, 54, 541, 32, 3254, 32541].
The SIC codes for Audentes Therapeutics are [37, 372].
Top Audentes Therapeutics Employees
-
5+5+
-
13
-
ViewShannise Brown-Fermin
Head Global Market Access Gene Therapy at Audentes Therapeutics
San Francisco, CA, US42 -
43
-
ViewChristine Leonard
Director, Gene Therapy Project Management at Audentes Therapeutics
San Francisco, CA, US33 -
View
Damiano Migani
Associate Director CMC Lead at Audentes Therapeutics
Emeryville, California, United States33 -
33
-
33
Related Companies
